Tisotumab vedotin in combination with carboplatin and pembrolizumab with or without bevacizumab in first-line recurrent or metastatic cervical cancer: First disclosure of arm H from the ENGOT-cx8/GOG-3024/innovaTV 205 study

Gynecologic Oncology 2026

View at publisher
Authors: Toon Van Gorp, Ignace Vergote, Leslie Randall, Jacqueline Maria Tromp, Domenica Lorusso, David Cibula, Ana Oaknin, Hannelore G Denys, Sharad Ghamande, Ingrid Boere, Carmela Pisano, Roisin O'Cearbhaill
+13 more Michal Zikán, Luis Manso Sánchez, Jean-Francois Baurain, Cara Mathews, Christine Gennigens, Jan Kümmel, Bohuslav Melichar, Michael Jon Chisamore, Umberto Conte, Kristian Windfeld, Henrik Hansen, Els Van Nieuwenhuysen, Bradley Monk
DOI: 10.1016/j.ygyno.2026.01.091
Cited by: 1

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments HER2/EGFR in Cancer Research Colorectal and Anal Carcinomas

Publication details

Journal / source
Gynecologic Oncology
Publisher
Elsevier BV
Volume
208
Pages
S37–S38
Publication date
23 April 2026
Language
EN